Metabolic syndrome and risk of subsequent colorectal cancer.


The metabolic syndrome and visceral obesity have an increasing prevalence and incidence in the general population. The actual prevalence of the metabolic syndrome is 24% in US population and between 24.6% and 30.9% in Europe. As demonstrated by many clinical trials (NAHANES III, INTERHART) the metabolic syndrome is associated with an increased risk of both… (More)


Cite this paper

@article{Pais2009MetabolicSA, title={Metabolic syndrome and risk of subsequent colorectal cancer.}, author={R Pais and Horațiu Silaghi and Alina-Cristina Silaghi and Mihai-Lucian Rusu and Dan-Lucian Dumitrascu}, journal={World journal of gastroenterology}, year={2009}, volume={15 41}, pages={5141-8} }